Navigation Links
Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More

Former US president Bill Clinton has once again lent a helping hand to HIV/ AIDS victims. After a fallout between the Brazil government and drug giant Merck over pricey anti-retroviral drugs, the Clinton foundation has helped diffuse the situation. Clinching a deal with two Indian pharmaceutical companies Cipla and Matrix, Bill Clinton announced the tie-up with the companies to provide second-line AVR drugs and a next generation one-pill-a-day drug.

Cipla and Matrix agreed to price their drugs on a cost-plus basis and collaborate with Clinton Foundation HIV and AIDS Initiative (CHAI) to lower production costs, in part, by securing lower prices for key raw materials and by addressing major chemistry challenges.

These agreements lower prices for 16 formulations of ARVs, which will be available to 66 developing countries in Africa, Asia, Latin America and the Caribbean through the Clinton Foundations Procurement Consortium, a release from CHAI added.

Bill Clinton was quoted: Seven million people in the developing world are in need of treatment for HIV/AIDS. We are trying to meet that need with the best medicine available today, and at prices that low-and middle-income countries can afford. I applaud Cipla and Matrix for their commitment to lower the cost of new drugs at the forefront of the fight against AIDS, and I thank UNITAID for the funds.

The AIDS virus infects nearly 39 million people globally, and has killed 25 million people since it was identified 25 years ago. Virtually all (95 percent) of people infected with the virus live in the developing world.

Experts say that by the year 2010, nearly half a million people in developing countries will need the drugs which currently cost far more money than the majority of developing countries can afford.

As Clinton was reported saying- companies will not live or die because of high price premiums for AIDS drugs in middle-income countries, but pati ents may.

The former US president states that while he upholds the belief in intellectual property and understands that manufacturers need to earn profits to keep the discovery and supply of AIDS drugs sustainable, that creed should not prevent essential life-saving medicines reaching those who need them in low and middle-income countries.


'"/>




Related medicine news :

1. Clintons new problem - Is the outgoing American president suffering from skin cancer?
2. AIDS testing gets support from Bill Clinton
3. Bill Clinton On A Kill, To Bell The Bulge Out of Schools
4. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
5. Clinton, Gates Highlight Treatment, Discrimination of AIDS
6. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
7. Clinton’s Nutrition Deal Cuts Junk Food on School Menu
8. Bill Clinton Says US Healthcare System Immoral
9. Hillary Clinton Speaks Up Strongly for Stem Cell Research
10. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
11. Kalam To Lay Foundation Of Vellore Research Center
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... Bioclinica® ... sponsors and CROs to speed clinical development, has released the industry’s only ... Bioclinica AGILE RTSM provides seamless clinical supply forecasting and management together ...
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... Scotch Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD ... with the treatment of acute or chronic problems, I focus on preventative care with all ... patient. If you have any questions, always feel free to contact my office and my ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: